James NE - Search Results

1

NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer.

De La Cruz P, McAdams J, Morales Aquino M, Fernandez AI, Elliott A, Lustberg M, Schorl C, Ribeiro JR, James NE. De La Cruz P, et al. Among authors: james ne. Breast Cancer Res. 2024 Dec 2;26(1):175. doi: 10.1186/s13058-024-01925-3. Breast Cancer Res. 2024. PMID: 39623404 Free PMC article.

2

Prognostic immunologic signatures in epithelial ovarian cancer.

James NE, Woodman M, Ribeiro JR. James NE, et al. Oncogene. 2022 Mar;41(10):1389-1396. doi: 10.1038/s41388-022-02181-5. Epub 2022 Jan 14. Oncogene. 2022. PMID: 35031772 Review.

3

Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways.

James NE, Woodman M, De La Cruz P, Eurich K, Ozsoy MA, Schorl C, Hanley LC, Ribeiro JR. James NE, et al. Front Immunol. 2022 Sep 5;13:965331. doi: 10.3389/fimmu.2022.965331. eCollection 2022. Front Immunol. 2022. PMID: 36131935 Free PMC article.

4

Multiplex serum immune profiling reveals circulating LAG-3 is associated with improved patient survival in high grade serous ovarian cancer.

Eurich K, De La Cruz P, Laguna A, Woodman M, McAdams J, Lips E, Ebott J, DiSilvestro J, Ribeiro J, James N. Eurich K, et al. Gynecol Oncol. 2023 Jul;174:200-207. doi: 10.1016/j.ygyno.2023.05.015. Epub 2023 May 22. Gynecol Oncol. 2023. PMID: 37224792 Free article.

5

Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment.

Ebott J, McAdams J, Kim C, Jansen C, Woodman M, De La Cruz P, Schrol C, Ribeiro J, James N. Ebott J, et al. Front Pharmacol. 2024 May 20;15:1375421. doi: 10.3389/fphar.2024.1375421. eCollection 2024. Front Pharmacol. 2024. PMID: 38831884 Free PMC article.

6

Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.

Ribeiro JR, Gaudet HM, Khan M, Schorl C, James NE, Oliver MT, DiSilvestro PA, Moore RG, Yano N. Ribeiro JR, et al. Among authors: james ne. Front Oncol. 2018 Jan 22;7:332. doi: 10.3389/fonc.2017.00332. eCollection 2017. Front Oncol. 2018. PMID: 29404274 Free PMC article.

7

Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.

James NE, Chichester C, Ribeiro JR. James NE, et al. Front Oncol. 2018 Apr 24;8:124. doi: 10.3389/fonc.2018.00124. eCollection 2018. Front Oncol. 2018. PMID: 29740539 Free PMC article. Review.

8

The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer.

James NE, Woodman M, DiSilvestro PA, Ribeiro JR. James NE, et al. Cancers (Basel). 2020 Aug 3;12(8):2150. doi: 10.3390/cancers12082150. Cancers (Basel). 2020. PMID: 32756436 Free PMC article. Review.

9

Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer.

James NE, Miller K, LaFranzo N, Lips E, Woodman M, Ou J, Ribeiro JR. James NE, et al. Front Oncol. 2021 Mar 5;11:622182. doi: 10.3389/fonc.2021.622182. eCollection 2021. Front Oncol. 2021. PMID: 33747935 Free PMC article.

10

A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.

James NE, Gura M, Woodman M, Freiman RN, Ribeiro JR. James NE, et al. Med Oncol. 2022 May 15;39(5):71. doi: 10.1007/s12032-022-01665-4. Med Oncol. 2022. PMID: 35568777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters